175 million Europeans have OSA - Send us your sleep apnoea video diary - Investigators examine OSA and affective disorders link - BBC Stories: Are you holding your breath in your sleep? -Try the Snore Centre Mobile App - Michael Oko explains cardiac anatomy
View this email in your browser

Snore Centre eNewsletter November 2019

Approximately 175 million Europeans have obstructive sleep apnoea

This is according to a recent study by connected health company ResMed, who in earlier work put the total number of people with sleep apnoea worldwide at a staggering 936 million – almost ten times higher than that previously estimated by the World Health Organization.

Dr Adam Benjafield, vice-president of medical affairs, speaking to Health Europa, said:

"ResMed convened a group of world-leading researchers in the sleep apnoea space to analyse published prevalence studies from 16 countries. When we combined those studies with population data from the United Nations, a more current prevalence figure quickly emerged. The overall human population has only risen 15% since 2007.

"We believe the reason the known prevalence of sleep apnoea has increased nearly tenfold since then is due to a combination of factors, including technological advancements that enable better detection of sleep apnoea, a higher prevalence of obesity and other conditions linked to the disease as well as changes to the scoring rules for diagnosing sleep apnoea."

175 million people in Europe are estimated to have sleep apnoea. What social/economic etc. impact is this likely to be having?

"While there are no studies estimating an exact figure, I can say with confidence the impact is significant in terms of quality of life and long-term health risks for those living with untreated sleep apnoea, as well as the toll on companies and Europe’s healthcare systems.

"In 2015, undiagnosed sleep apnoea cost the United States nearly $150bn (~€130bn), as a result of related lost productivity, motor vehicle accidents and workplace accidents, as well as healthcare costs and medications prescribed to treat conditions associated with these untreated apnoeas.1 Europe has threefold the amount of people living with sleep apnoea as the United States, and it’s reasonable to imagine that the impact is significantly higher as well."

Continue reading...

Send us your sleep apnoea video diary

As part of our efforts to raise awareness about sleep apnoea The Sleeping Disorders Centre is asking our patients and all sufferers of this debilitating condition to record their experience in a video diary and share it with us.

We believe that much more needs to be done to increase the public's knowledge of sleep apnoea and encourage potential sufferers to seek help. Studies have shown that obstructive sleep apnoea is often undiagnosed, and a significant percentage of sufferers continue to struggle to live with the condition unaided by effective CPAP treatment.  

If enough people who have sleep apnoea and are undergoing CPAP treatment can speak directly to the public about their experience and lead to more people recognising the symptoms in themselves and seeking help, then we can spread the word to a wider audience.

There are several ways you can do this.

Either: Send us your video via email (ideally sharing via cloud storage such as icloud, Google Drive or Dropbox, due to file size) and with your permission we can publish on our website and social media...

Or: Self publish your video on Twitter, Facebook or YouTube (or other site) and send us the link.

You can send your video or link to or share on social media with @Snore_Centre or using the hashtag #sleepapnoeadiary

Investigators Examine OSA and Affective Disorders link

Obstructive sleep apnea (OSA) has been linked with several health conditions including hypertension, cardiovascular disease, stroke, and type 2 diabetes. Researchers set out to determine whether the syndrome might also increase the risk for mood disorders, including depression and anxiety.

The investigators found that people with OSA were nearly 3 times as likely to be diagnosed with depression, and nearly twice as likely to be diagnosed with anxiety as those in the control group. Of the cohort, women with OSA were more likely to develop depressive and anxiety disorders than men with OSA. Positive airway pressure and oral appliances used to treat OSA were not covered under the Korea NHIS-NSC, therefore the investigators were unable to determine if patients undergoing these therapies had a lower incidence of affective disorders.

The researchers concluded that OSA is associated with an increased risk for mood disorders, specifically depression and anxiety. They cautioned that further studies are needed to confirm their findings and explore possible underlying mechanisms, including potential causality.

The researchers examined 197 patients with OSA diagnosed between 2004 and 2006 and 788 people without the condition matched for age, sex, and socioeconomic and health characteristics. None of the participants, selected from the Korea National Health Insurance Service-National Sample Cohort (NHIS-NSC), had been diagnosed with depressive or anxiety disorders before the first diagnosis of OSA.

Continue reading...

BBC Stories: Are you holding your breath in your sleep?

Watch the video on the BBC

Have You Tried Our Mobile App?


Keep up with all the latest news and research on sleep apnoea from the Sleeping Disorders Centre with this nifty free app. Here you can find all our social media channels (YouTube/Facebook/Twitter/Blog) all in one place, right on your phone.

Be sure to let us know what you think of our app by leaving a review on iTunes or the Google Play Store. All your feedback is valuable to us.


Download the app for Android devices

Download the app for iOS devices

Michael Oko explains cardiac anatomy using virtual reality  ​

Forward to Friend

Do you snore loudly?

To find out if you are at risk of sleep apnoea take the STOP-BANG test today
Copyright © 2019 Guy Rowland Public Relations, All rights reserved.
unsubscribe from this list    update subscription preferences 

Email Marketing Powered by Mailchimp